98 related articles for article (PubMed ID: 1801158)
1. Longterm follow-up of onchocerciasis patients in Latin America after treatment and retreatment with amocarzine. Preliminary results.
Poltera AA; Zea-Flores G; Guderian R; Striebel HP; Moran M
Trop Med Parasitol; 1991 Sep; 42(3):308-13. PubMed ID: 1801158
[TBL] [Abstract][Full Text] [Related]
2. Amocarzine investigated as oral onchocercacidal drug in 272 adult male patients from Guatemala. Results from three dose regimens spread over three days.
Zea-Flores G; Beltranena F; Poltera AA; Lopez M; Moran M; Zea-Flores CE; de Ramirez I; Lecaillon JB; Zak F; Palomo M
Trop Med Parasitol; 1991 Sep; 42(3):240-62. PubMed ID: 1801152
[TBL] [Abstract][Full Text] [Related]
3. Onchocercacidal effect of three drug regimens of amocarzine in 148 patients of two races and both sexes from Esmeraldas, Ecuador.
Guderian RH; Anselmi M; Proaño R; Naranjo A; Poltera AA; Moran M; Lecaillon JB; Zak F; Cascante S
Trop Med Parasitol; 1991 Sep; 42(3):263-85. PubMed ID: 1801153
[TBL] [Abstract][Full Text] [Related]
4. Onchocercacidal effects of amocarzine (CGP 6140) in Latin America.
Poltera AA; Zea-Flores G; Guderian R; Beltranena F; Proana R; Moran M; Zak F; Striebel HP
Lancet; 1991 Mar; 337(8741):583-4. PubMed ID: 1671945
[TBL] [Abstract][Full Text] [Related]
5. Microfilaricidal effect of amocarzine in skin punch biopsies of patients with onchocerciasis from Latin America.
Zak F; Guderian R; Zea-Flores G; Guevara A; Moran M; Poltera AA
Trop Med Parasitol; 1991 Sep; 42(3):294-302. PubMed ID: 1801156
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
Awadzi K; Opoku NO; Attah SK; Addy ET; Duke BO; Nyame PK; Kshirsagar NA
Ann Trop Med Parasitol; 1997 Apr; 91(3):281-96. PubMed ID: 9229021
[TBL] [Abstract][Full Text] [Related]
7. Use of an ophthalmologic ultrasoundscanner in human onchocercal skin nodules for non-invasive sequential assessment during a macrofilaricidal trial with amocarzine in Guatemala. The first experiences.
Poltera AA; Reyna O; Zea-Flores G; Beltranena F; Nowell de Arevalo A; Zak F
Trop Med Parasitol; 1991 Sep; 42(3):303-7. PubMed ID: 1801157
[TBL] [Abstract][Full Text] [Related]
8. Fine structure of microfilariae in the skin of onchocerciasis patients after exposure to amocarzine.
Büttner G; Zea-Flores G; Poltera AA; Büttner DW
Trop Med Parasitol; 1991 Sep; 42(3):314-8. PubMed ID: 1801159
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
[TBL] [Abstract][Full Text] [Related]
10. Immunoelectron microscopic evidence for release of eosinophil granule matrix protein onto microfilariae of Onchocerca volvulus in the skin after exposure to amocarzine.
Gutiérrez-Peña EJ; Knab J; Büttner DW
Parasitol Res; 1998 Aug; 84(8):607-15. PubMed ID: 9747932
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle.
Renz A; Trees AJ; Achu-Kwi D; Edwards G; Wahl G
Trop Med Parasitol; 1995 Mar; 46(1):31-7. PubMed ID: 7631125
[TBL] [Abstract][Full Text] [Related]
12. Small-scale trials of six drugs against Onchocerca volvulus.
Kale O
Tropenmed Parasitol; 1978 Jun; 29(2):163-7. PubMed ID: 675837
[TBL] [Abstract][Full Text] [Related]
13. Research notes from the Onchocerciasis Chemotherapy Research Centre, Ghana.
Awadzi K
Ann Trop Med Parasitol; 1997 Oct; 91(7):703-11. PubMed ID: 9625924
[TBL] [Abstract][Full Text] [Related]
14. Influence of food related to dose on the pharmacokinetics of amocarzine and of its N-oxide metabolite, CGP 13 231, after oral administration to 20 onchocerciasis male patients from Guatemala.
Lecaillon JB; Poltera AA; Zea-Flores G; de Ramirez I; Nowell de Arevalo A
Trop Med Parasitol; 1991 Sep; 42(3):286-90. PubMed ID: 1801154
[TBL] [Abstract][Full Text] [Related]
15. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT; Lazdins-Helds JK; Ahmed K; Boatin BA; Boakye DA; Edwards G
Ann Trop Med Parasitol; 2004 Jun; 98(4):359-70. PubMed ID: 15228717
[TBL] [Abstract][Full Text] [Related]
16. Polymerase chain reaction-based assessment after macrofilaricidal therapy in Onchocerca volvulus infection.
Nutman TB; Parredes W; Kubofcik J; Guderian RH
J Infect Dis; 1996 Mar; 173(3):773-6. PubMed ID: 8627052
[TBL] [Abstract][Full Text] [Related]
17. Progress and challenges in the discovery of macrofilaricidal drugs.
Geary TG; Mackenzie CD
Expert Rev Anti Infect Ther; 2011 Aug; 9(8):681-95. PubMed ID: 21819332
[TBL] [Abstract][Full Text] [Related]
18. Suramin in the treatment of onchocerciasis: the efficacy of low doses on the parasite in an area with vector control.
Schulz-Key H; Karam M; Prost A
Trop Med Parasitol; 1985 Dec; 36(4):244-8. PubMed ID: 4089476
[TBL] [Abstract][Full Text] [Related]
19. Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models.
Sjoberg HT; Pionnier N; Aljayyoussi G; Metuge HM; Njouendou AJ; Chunda VC; Fombad FF; Tayong DB; Gandjui NVT; Akumtoh DN; Chounna PWN; Ndzeshang BL; Lachaud S; Tekle F; Quirynen L; Engelen M; Baeten B; Steven A; Ward SA; Taylor MJ; Wanji S; Turner JD
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006356. PubMed ID: 30650071
[TBL] [Abstract][Full Text] [Related]
20. The effect of drug treatment on the pattern of emergence of Onchocerca volvulus microfilariae from skin snips.
Kale OO
J Helminthol; 1981 Jun; 55(2):79-83. PubMed ID: 7264274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
